Across the United States, a quiet but significant shift is unfolding in how some patients access their doctors. Direct primary care — a model where patients pay a monthly membership fee directly to their physician, bypassing insurance entirely — has grown from a handful of practices to an estimated 1,800 or more nationwide. Proponents call it a return to relationship-based medicine.

The appeal is intuitive. Smaller patient panels, longer appointments, same-day access, and a price tag that often looks surprisingly affordable. For physicians burned out by insurance paperwork, it promises professional renewal. For patients frustrated by ten-minute visits and weeks-long waits, it promises something that feels like actual care.

But a policy question lurks beneath the enthusiasm. If primary care's best doctors can build sustainable practices serving patients who can afford monthly fees, what happens to everyone else? Direct primary care sits at a fascinating intersection of market innovation and health equity — and the tension between those forces deserves careful examination.

Direct primary care operates on a strikingly simple premise. Patients pay a flat monthly fee — typically between $50 and $150 per adult — directly to their physician's practice. In return, they receive comprehensive primary care services without copays, deductibles, or insurance claims. The practice doesn't bill insurers, doesn't employ coding staff, and doesn't navigate prior authorizations. This administrative simplicity is the engine of the entire model.

Most DPC practices maintain patient panels of 400 to 800, compared to the 2,000 to 2,500 patients a conventional primary care physician might manage. That ratio changes everything about the clinical encounter. Appointments commonly run 30 to 60 minutes. Many practices offer same-day or next-day visits, direct phone and text access to the physician, and basic lab work or procedures included in the membership fee. Some negotiate wholesale pricing on medications and imaging, passing savings to patients.

The financial architecture matters for understanding who this model serves. DPC memberships are not insurance — they don't cover hospitalizations, specialist care, or catastrophic events. Most policy experts recommend that DPC patients also carry a high-deductible health plan or catastrophic coverage for everything beyond primary care. This means the true cost of a DPC arrangement is the membership fee plus some form of insurance, which shapes who can realistically participate.

From a regulatory standpoint, DPC occupies an evolving landscape. Over 35 states have passed legislation clarifying that DPC agreements are not insurance products, shielding practices from insurance regulation. Some legislative proposals have explored whether DPC memberships could be paired with Health Savings Accounts or integrated into employer benefit packages. These regulatory choices will significantly influence whether DPC remains a niche alternative or scales into something more systemic.

Takeaway

A policy model's elegance on paper matters less than its economic prerequisites. Direct primary care removes administrative complexity but adds a new financial layer — and who can afford that layer determines who benefits.

The honest assessment of DPC's evidence base starts with an important caveat: rigorous, large-scale studies remain scarce. Most available data comes from practice-level reports, patient surveys, and a small number of employer-sponsored evaluations. This isn't unusual for a relatively young care delivery model, but it means that confident claims about DPC's superiority should be treated with appropriate caution.

What evidence does exist points in encouraging directions. Several employer case studies — notably from companies like Nextera and Qliance — have reported reductions in emergency department visits, hospital admissions, and total healthcare spending among employees enrolled in DPC arrangements. Patient satisfaction scores tend to be high, with members frequently citing access, relationship continuity, and time with their physician as key factors. A 2020 study published in the Journal of the American Board of Family Medicine found DPC patients reported significantly better care experiences than national benchmarks.

However, these findings carry significant selection bias concerns. Patients who choose DPC — and can afford it — may already be healthier, more health-literate, and more engaged in their care. Employers who offer DPC benefits may have different workforce demographics than the general population. Disentangling the model's effects from the population's characteristics is the central methodological challenge that existing research has not yet resolved.

The utilization patterns are genuinely interesting from a policy perspective. DPC patients appear to use primary care services more frequently while using costly downstream services less. If this pattern holds under rigorous evaluation, it would support a core premise of health policy: that investing in accessible, relationship-based primary care reduces total system costs. But the "if" in that sentence is doing heavy analytical lifting.

Takeaway

Promising early results are not the same as proven effectiveness. When a model self-selects for healthier, wealthier patients, positive outcomes may reflect who walks through the door as much as what happens inside.

Here is the uncomfortable policy tension at the heart of direct primary care's growth. The United States already faces a primary care workforce shortage, with the Association of American Medical Colleges projecting a deficit of up to 48,000 primary care physicians by 2034. Every physician who transitions to a DPC practice with 600 patients was previously — at least in theory — available to serve 2,000 or more patients in a traditional setting. The arithmetic of workforce reallocation matters.

DPC's pricing, while often described as affordable, requires consistent monthly spending that many Americans simply cannot manage. For a family of four, membership fees alone could run $300 to $500 monthly before adding the cost of catastrophic insurance coverage. Medicaid beneficiaries, uninsured individuals, and many lower-income workers are effectively excluded — not by explicit policy, but by economic reality. The result is a model that improves care for those who can pay while potentially thinning the provider supply for those who cannot.

Some DPC advocates push back on this framing, arguing that a healthier primary care market benefits everyone by demonstrating what effective practice looks like, reducing physician burnout, and keeping doctors in primary care who might otherwise leave. Others point to practices that offer sliding-scale fees or reserve slots for lower-income patients. These are meaningful counterarguments, but they describe exceptions rather than structural solutions.

The deeper policy question is whether DPC's growth represents a market correction — restoring primary care to its proper function — or an early symptom of a stratifying system where access to a real physician relationship becomes a function of household income. Both can be true simultaneously, and that's precisely what makes this a policy challenge rather than a simple success story. The answer depends less on the model itself than on the policy environment built around it.

Takeaway

Innovation that works brilliantly for those who can access it but is structurally unavailable to those who need it most isn't just incomplete — it risks widening the gap it claims to address.

Direct primary care genuinely solves real problems — administrative burden, rushed visits, physician burnout, and the erosion of the patient-doctor relationship. These aren't trivial gains, and dismissing the model outright would be intellectually dishonest.

But health policy must evaluate innovations not only by what they achieve for participants, but by their system-level effects. A model that improves care for some while potentially reducing access for others demands policy guardrails — workforce protections, subsidized access pathways, and rigorous outcome research that accounts for selection effects.

The question isn't whether direct primary care is good medicine. It often is. The question is whether we're willing to build the policy architecture that ensures better primary care doesn't become a privilege reserved for those who can write a monthly check.